Intervention

MP-214 6mg

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

3 shown

Long-Term Study of MP-214 in Patients With SchizophreniaNCT01626872 · 2012-09-01

A Pharmacokinetic Study of MP-214 in Patients With SchizophreniaNCT01626859 · 2012-05-01

Safety and Efficacy of MP-214 in Patients With SchizophreniaNCT01625000 · 2012-05-01

Common conditions

Leading sponsors

Tanabe Pharma Corporation3

Trial status mix

COMPLETED3

Phase mix

PHASE23

PHASE33

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.